Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 10;20(4):130-135.
doi: 10.1002/cld.1239. eCollection 2022 Oct.

Posttransplant considerations in autoimmune liver disease: Recurrence of disease and de novo

Alexis Gumm  1 , Antonio Perez-Atayde  2 , Andrew Wehrman  1
Affiliations
Review

Posttransplant considerations in autoimmune liver disease: Recurrence of disease and de novo

Alexis Gumm et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

A.W. received grants from Albireo.

Figures

FIGURE 1
FIGURE 1
Posttransplant recurrent PSC. (A) Branching portal tract with mild chronic inflammatory infiltrate. Two interlobular bile ducts (between arrowheads) show periductal edema and inflammation. (B) Prominent periductal edema and periductal fibrosis (between arrowheads). (C) The periductal inflammatory infiltrate here is moderate and primarily lymphoplasmacytic between arrowheads). (D) The periductal fibrosis, onion skinning type, is better observed with the Masson trichrome special stain highlighting the concentric wisps of mature collagen in blue (between arrowheads).
FIGURE 2
FIGURE 2
Treatment strategies for recurrent AIH post‐LT.
See this image and copyright information in PMC

References

    1. Webb GJ, Rana A, Hodson J, Akhtar MZ, Ferguson JW, Neuberger JM, et al. Twenty‐year comparative analysis of patients with autoimmune liver diseases on transplant waitlists. Clin Gastroenterol Hepatol. 2018. Feb;16(2):278–87.e7. 10.1016/j.cgh.2017.09.062 - DOI - PubMed
    1. Mendes F, Couto CA, Levy C. Recurrent and de novo autoimmune liver diseases. Clin Liver Dis. 2011;15:859–78. - PubMed
    1. Hayashi M, Keeffe EB, Krams SM, Martinez OM, Ojogho ON, So SK, et al. Allograft rejection after liver transplantation for autoimmune liver diseases. Liver Transpl Surg. 1998. May;4(3):208–14. 10.1002/lt.500040313 - DOI - PubMed
    1. Milkiewicz P, Gunson B, Saksena S, Hathaway M, Hubscher SG, Elias E. Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors. Transplantation. 2000. Aug 15;70(3):477–80. 10.1097/00007890-200008150-00014 - DOI - PubMed
    1. Heinemann M, Adam R, Berenguer M, Mirza D, Malek‐Hosseini SA, O'Grady JG, et al. Longterm survival after liver transplantation for autoimmune hepatitis: results from the European Liver Transplant Registry. Liver Transpl. 2020. Jul;26(7):866–77. 10.1002/lt.25739 - DOI - PubMed